| Entry |
|
|---|
| Name |
Minodronic acid hydrate (JAN);
Bonoteo (TN);
Recalbon (TN)
|
|---|
| Formula |
C9H12N2O7P2. H2O
|
|---|
| Exact mass |
340.0225
|
|---|
| Mol weight |
340.1636
|
|---|
| Structure |
   |
|---|
| Class |
|
|---|
| Remark |
| Therapeutic category: | 3999 |
|
|---|
| Efficacy |
Antiresorptive, Osteoporosis agent, Farnesylpyrophosphate synthetase inhibitor |
|---|
| Comment |
Bisphosphonate
|
|---|
| Target |
|
|---|
| Pathway |
| hsa00900 | Terpenoid backbone biosynthesis |
|
|---|
| Interaction |
|
|---|
| Structure map |
|
|---|
| Brite |
Therapeutic category of drugs in Japan [BR:br08301]
3 Agents affecting metabolism
39 Other agents affecting metabolism
399 Miscellaneous
3999 Others
D09198 Minodronic acid hydrate (JAN)
Target-based classification of drugs [BR:br08310]
Enzymes
Transferases (EC2)
Alkyl/Aryl transferases
FDPS
D09198 Minodronic acid hydrate (JAN) <JP>
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D09198
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D09198
 |
|---|
| Other DBs |
|
|---|
| LinkDB |
 |
|---|
| KCF data |
ATOM 21
1 C1d C 23.1352 -24.8855
2 P1b P 24.3313 -25.5892
3 P1b P 21.9390 -25.5892
4 C1b C 23.1352 -23.4783
5 C8y C 24.3313 -22.7747
6 O1c O 25.5275 -24.8855
7 O1c O 24.3313 -26.9964
8 O1c O 25.5275 -26.2928
9 O1c O 20.7428 -24.8855
10 O1c O 21.9390 -26.9964
11 O1c O 20.7428 -26.2928
12 C8x C 25.6682 -23.1968
13 N5x N 26.5126 -22.0710
14 C8y C 25.6682 -20.9452
15 N4y N 24.3313 -21.3674
16 C8x C 25.9722 -19.5712
17 C8x C 24.9342 -18.6209
18 C8x C 23.5974 -19.0431
19 C8x C 23.2934 -20.4171
20 O1a O 23.1352 -26.2928
21 O0 O 28.8400 -24.0800
BOND 21
1 1 2 1
2 1 3 1
3 1 4 1
4 4 5 1
5 2 6 2
6 2 7 1
7 2 8 1
8 3 9 2
9 3 10 1
10 3 11 1
11 5 12 2
12 12 13 1
13 13 14 2
14 14 15 1
15 5 15 1
16 14 16 1
17 16 17 2
18 17 18 1
19 18 19 2
20 15 19 1
21 1 20 1
|
|---|
